EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Products in Renal-Associated Drug Discovery

Wasco Wruck iD, Afua Kobi Ampem Genfi iD, James Adjaye iD

Antioxidants · 11.08.2023 · 12 (8) · 1599

DOI: 10.3390/antiox12081599 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 11.08.2023. Verfasst von Wasco Wruck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global increase in the incidence of kidney failure constitutes a major public health problem. Kidney disease is classified into acute and chronic: acute kidney injury (AKI) is associated with an abrupt decline in kidney function and chronic kidney disease (CKD) with chronic renal failure for more than three months. Although both kidney syndromes are multifactorial, inflammation and oxidative stress play major roles in the diversity of processes leading to these kidney malfunctions. Here, we reviewed various publications on medicinal plants with antioxidant and anti-inflammatory properties with the potential to treat and manage kidney-associated diseases in rodent models. Additionally, we conducted a meta-analysis to identify gene signatures and associated biological processes perturbed in human and mouse cells treated with antioxidants such as epigallocatechin gallate (EGCG), the active ingredient in green tea, and the mushroom Ganoderma lucidum (GL) and in kidney disease rodent models. We identified EGCG- and GL-regulated gene signatures linked to metabolism; inflammation (NRG1, E2F1, NFKB1 and JUN); ion signalling; transport; renal processes (SLC12A1 and LOX) and VEGF, ERBB and BDNF signalling. Medicinal plant extracts are proving to be effective for the prevention, management and treatment of kidney-associated diseases; however, more detailed characterisations of their targets are needed to enable more trust in their application in the management of kidney-associated diseases.

Schlagwörter

Stichwörter der Autor:innen

AKICKDanti-inflammatoryantioxidantnatural medicinal products

Autor:innen und Institutionen

  • Institute for Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany.
  • Department of Biochemistry and Molecular Biology, Faculty of Biosciences, University for Development Studies, Nyankpala P.O. Box TL 1882, Ghana.
  • EGA Institute for Women's Health, Zayed Centre for Research into Rare Diseases in Children (ZCR), University College London (UCL), 20 Guilford Street, London WC1N 1DZ, UK.

ORCID-Profile: Wasco Wruck, Afua Kobi Ampem Genfi, James Adjaye

Zitieren

APA

Wruck, W., Genfi, A. K. A., & Adjaye, J. (2023). Natural Products in Renal-Associated Drug Discovery. Antioxidants, 12(8), 1599. https://doi.org/10.3390/antiox12081599

Vancouver

Wruck W, Genfi AKA, Adjaye J. Natural Products in Renal-Associated Drug Discovery. Antioxidants. 2023;12(8):1599. doi:10.3390/antiox12081599

BibTeX
@article{Wruck2023,
  author = {Wruck, Wasco and Genfi, Afua Kobi Ampem and Adjaye, James},
  title = {Natural Products in Renal-Associated Drug Discovery},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1599},
  doi = {10.3390/antiox12081599}
}
Kostenlos starten →